Human Umbilical Cord Blood Cells Alter Blood and Spleen Cell Populations After Stroke

Translational Stroke Research

Volumn 3, Issue 4, 2012, Pages 491-499

  Golden, J E ^a   Shahaduzzaman, M ^a   Wabnitz, A ^a   Green, S ^a   Womble, T A ^a   Sanberg, P R ^a   Pennypacker, K R ^a   Willing, A E ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

Author keywords

B cells; Macrophage; Monocytes; Mononuclear cells; Stroke; T cells

Indexed keywords

CONCANAVALIN A;

ANIMAL CELL; ANIMAL EUTHANASIA; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL POPULATION; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; MACROPHAGE; MALE; MONOCYTE; MONONUCLEAR CELL; NONHUMAN; PRIORITY JOURNAL; RAT; SPLEEN CELL; T LYMPHOCYTE; UMBILICAL CORD BLOOD;

EID: 84869863896     PISSN: 18684483     EISSN: 1868601X     Source Type: Journal    
DOI: 10.1007/s12975-012-0208-3     Document Type: Article

References (33)

1. Vendrame M, Cassady CJ, Newcomb J, Butler T, Pennypacker KR, Zigova T, et al. Infusion of human umbilical cord blood cells in a rat model of stroke dose-dependently rescues behavioral deficits and reduces infarct volume. Stroke. 2004; 35: 2390-5.
2. Boltze J, Schmidt UR, Reich DM, Kranz A, Reymann KG, Strassburger M, et al. Determination of the therapeutic time window for human umbilical cord blood mononuclear cell transplantation following experimental stroke in rats. Cell Transplant. 2012; 21(6): 1199-1211.
3. Newcomb JD, Ajmo CT, Davis Sanberg C, Sanberg PR, Pennypacker KR, Willing AE. Timing of cord blood treatment after experimental stroke determines therapeutic efficacy. Cell Transplant. 2006; 15(3): 213-23.
4. Willing AE, Lixian J, Milliken M, Poulos S, Zigova T, Song S, et al. Intravenous versus intrastriatal cord blood administration in a rodent model of stroke. J Neurosci Res. 2003; 73(3): 296-307.
5. Borlongan CV, Hadman M, Davis Sanberg C, Sanberg PR. CNS entry of peripherally injected umbilical cord blood cells is not required for neuroprotection in stroke. Stroke. 2004; 35(10): 2385-9.
6. Keimpema E, Fokkens MR, Nagy Z, Agoston V, Luiten PG, Nyakas C, et al. Early transient presence of implanted bone marrow stem cells reduces lesion size after cerebral ischaemia in adult rats. Neuropathol Appl Neurobiol. 2009; 35(1): 89-102.
7. Fischer UM, Harting MT, Jimenez F, Monzon-Posadas WO, Xue H, Savitz SI, et al. Pulmonary passage is a major obstacle for intravenous stem cell delivery: the pulmonary first-pass effect. Stem Cells Dev. 2009; 18(5): 683-92.
8. Lappalainen RS, Narkilahti S, Huhtala T, Liimatainen T, Suuronen T, Narvanen A, et al. The SPECT imaging shows the accumulation of neural progenitor cells into internal organs after systemic administration in middle cerebral artery occlusion rats. Neurosci Lett. 2008; 440(3): 246-50.
9. Battistella V, de Freitas GR, da Fonseca LM, Mercante D, Gutfilen B, Goldenberg RC, et al. Safety of autologous bone marrow mononuclear cell transplantation in patients with nonacute ischemic stroke. Regen Med. 2011; 6(1): 45-52.
10. Vendrame M, Gemma C, Pennypacker KR, Bickford PC, Davis Sanberg C, Sanberg PR, et al. Cord blood rescues stroke-induced changes in splenocyte phenotype and function. Exp Neurol. 2006; 199: 191-200.
11. Leonardo C, Hall AA, Collier LA, Ajmo Jr CT, Willing AE, Pennypacker KR. HUCB cell therapy blocks the morphological change and recruitment of CD11b-expressing, isolectin-binding proinflammatory cells after MCAO. J Neurosci Res. 2010; 88: 1213-22.
12. Vendrame M, Gemma C, de Mesquita D, Collier L, Bickford PC, Davis Sanberg C, et al. Anti-inflammatory effects of human cord blood cells in a rat model of stroke. Stem Cells Dev. 2005; 14: 595-604.
13. Lee ST, Chu K, Jung KH, Kim SJ, Kim DH, Kang KM, et al. Anti-inflammatory mechanism of intravascular neural stem cell transplantation in haemorrhagic stroke. Brain. 2008; 131(Pt 3): 616-29.
14. Taguchi A, Soma T, Tanaka H, Kanda T, Nishimura H, Yoshikawa H, et al. Administration of CD34+ cells after stroke enhances neurogenesis via angiogenesis in a mouse model. J Clin Invest. 2004; 114(3): 330-8.
15. Boltze J, Kowalski I, Geiger K, Reich D, Gunther A, Buhrle C, et al. Experimental treatment of stroke in spontaneously hypertensive rats by CD34+ and CD34- cord blood cells. Ger Med Sci. 2005; 3: Doc09.
16. Boltze J, Reich DM, Hau S, Reymann KG, Strassburger M, Lobsein D, et al. Assessment of neuroprotective effects of human umbilical cord blood mononuclear cell subpopulations in vitro and in vivo. Cell Transplant. 2012; 21: 723-37.
17. Nystedt J, Makinen S, Laine J, Jolkkonen J. Human cord blood CD34+ cells and behavioral recovery following focal cerebral ischemia in rats. Acta Neurobiologie Experimentalis. 2006; 66: 293-300.
18. Offner H, Subramanian S, Parker SM, Afentoulis ME, Vandenbark AA, Hurn PD. Experimental stroke induces massive, rapid activation of the peripheral immune system. J Cereb Blood Flow Metab. 2006; 26(5): 654-65.
19. Offner H, Subramanian S, Parker SM, Wang C, Afentoulis ME, Lewis A, et al. Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages. J Immunol. 2006; 176: 6523-31.
20. Ajmo JCT, Collier LA, Leonardo CC, Hall AA, Cuevas J, Green SM, et al. Blockade of adrenoreceptors inhibits the splenic response to stroke. Exp Neurol. 2009; 218: 47-55.
21. Rainsford E, Reen DJ. Interleukin 10, produced in abundance by human newborn T cells, may be the regulator of increased tolerance associated with cord blood stem cell transplantation. Br J Haematol. 2002; 116(3): 702-9.
22. Mueller CG, Boix C, Kwan W-H, Daussy C, Fournier E, Fridman WH, et al. Critical role of monocytes to support normal B cell and diffuse large B cell lymphoma survival and proliferation. J Leukoc Biol. 2007; 82(3): 567-75.
23. Jagannathan M, McDonnell M, Liang Y, Hasturk H, Hetzel J, Rubin D, et al. Toll-like receptors regulate B cell cytokine production in patients with diabetes. Diabetol. 2010; 53(7): 1461-71.
24. Vanneaux V, El-Ayoubi F, Delmau C, Driancourt C, Lecourt S, Grelier A, et al. In vitro and in vivo analysis of endothelial progenitor cells from cryopreserved umbilical cord blood: are we ready for clinical application? Cell Transplant. 2010; 19(9): 1143-55.
25. Chang JW, Hung SP, Wu HH, Wu WM, Yang AH, Tsai HL, et al. Therapeutic effects of umbilical cord blood-derived mesenchymal stem cell transplantation in experimental lupus nephritis. Cell Transplant. 2011; 20(2): 245-57.
26. Ivanovic Z, Duchez P, Chevaleyre J, Vlaski M, Lafarge X, Dazey B, et al. Clinical-scale cultures of cord blood CD34(+) cells to amplify committed progenitors and maintain stem cell activity. Cell Transplant. 2011; 20(9): 1453-63.
27. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2005; 105(4): 1815-22.
28. Geissmann F, Auffray C, Palframan R, Wirrig C, Ciocca A, Campisi L, et al. Blood monocytes: distinct subsets, how they relate to dendritic cells, and their possible roles in the regulation of T-cell responses. Immunol Cell Biol. 2008; 86: 398-408.
29. McGuckin CP, Pearce D, Forraz N, Tooze JA, Watt SM, Pettengell R. Multiparametric analysis of immature cell populations in umbilical cord blood and bone marrow. Eur J Haematol. 2003; 71(5): 341-50.
30. Saadi S, Platt JL. Immunology of xenotransplantation. Life Sci. 1998; 62(5): 365-87.
31. Saadi S, Holzknecht RA, Patte CP, Stern DM, Platt JL. Complement-mediated regulation of tissue factor activity in endothelium. J Exp Med. 1995; 182(6): 1807-14.
32. Mezey E, Mayer B, Nemeth K. Unexpected roles for bone marrow stromal cells (or MSCs): a real promise for cellular, but not replacement, therapy. Oral Dis. 2010; 16(2): 129-35.
33. Nemeth K, Leelahavanichkul A, Yuen PS, Mayer B, Parmelee A, Doi K, et al. Bone marrow stromal cells attenuate sepsis via prostaglandin E(2)-dependent reprogramming of host macrophages to increase their interleukin-10 production. Nat Med. 2009; 15(1): 42-9.